Showing results (2001-2010 of 2,190) with videos related to

Sort By:
Pageof 219
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 18, 2020
Childhood maltreatment and cognitive functioning: the role of depression, parental education, and polygenic predispositionJanik Goltermann, Ronny Redlich, Dominik Grotegerd, et al.
JAMA Psychiatry|July 27, 2022
Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder Across Neuroimaging ModalitiesNils R Winter, Ramona Leenings, Jan Ernsting, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2026
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase 3 FIGHT-302 TrialTanios S Bekaii-Saab, Davide Melisi, Hanneke Wilmink, et al.
Biological Psychiatry|May 19, 2023
Brain Structural Network Connectivity of Formal Thought Disorder Dimensions in Affective and Psychotic DisordersFrederike Stein, Marius Gruber, Marco Mauritz, et al.
Human Cell|August 4, 2025
Establishment of Coala: a novel 3D and 2D cancer cell line derived from colorectal cancer liver metastasisSandra Mersakova, Juraj Marcinek, Dusan Brany, et al.
Frontiers in Neurology|June 14, 2019
Apolipoprotein E Homozygous ε4 Allele Status: A Deteriorating Effect on Visuospatial Working Memory and Global Brain StructureJanik Goltermann, Ronny Redlich, Katharina Dohm, et al.
Cancer Research Communications|March 27, 2023
Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer ImmunotherapyMichael R Paillasse, Michael Esquerré, Florie A Bertrand, et al.
Journal of Neurology|May 5, 2022
Genetic modifiers of upper limb function in Duchenne muscular dystrophyDaniele Sabbatini, Aurora Fusto, Sara Vianello, et al.
Psychological Medicine|February 8, 2023
Cognitive performance and brain structural connectome alterations in major depressive disorderMarius Gruber, Marco Mauritz, Susanne Meinert, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2015
90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphomaJohn E Janik, John C Morris, Deirdre O'Mahony, et al.
Pageof 219